✦ LIBER ✦

P129 Arthritis and nephritis as clinical manifestation of psoriasis

✍ Scribed by I.Y. Schakhtmeister; E.A. Hilal; I.V. Sharipova

Book ID: 118604565
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 121 KB
Volume: 9
Category: Article
ISSN: 0926-9959
DOI: 10.1016/s0926-9959(97)89600-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Common clinical features and disease mec

Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis

✍ Wendy Myers; Mobolaji Opeola; Alice B. Gottlieb 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 350 KB

More than skin deep: atherosclerosis as

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis

✍ A.B. Alexandroff; M. Pauriah; R.D.R. Camp; C.C. Lang; A.D. Struthers; D.J. Armst 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Pyoderma gangrenosum as first clinical m

Pyoderma gangrenosum as first clinical manifestation of gastric adenocarcinoma

✍ AE da Costa França; LK Braga Salvino; SH Rodrigues Leite; JG Paraíso Ferraz; TD 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Wheezing as the sole clinical manifestat

Wheezing as the sole clinical manifestation of cor triatriatum

✍ Antonello Pisanti; Renato Vitiello 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Clinical images: Multilocular tenosynovi

Clinical images: Multilocular tenosynovitis as a manifestation of sarcoidosis

✍ Florian Kollert; Margretha L. Hadiprasetya; Corina Probst; Leonora Houet; Herber 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Cytochrome P450 pharmacogenetics as a pr

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

✍ Kazuki Takada; Million Arefayene; Zeruesenay Desta; Cheryl H. Yarboro; Dimitrios 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## Objective Pulse cyclophosphamide is the treatment of choice for severe lupus nephritis. However, not all patients respond to this therapy, and gonadal toxicity is of particular concern. Cyclophosphamide is a prodrug that requires activation by cytochrome P450 (CYP) enzymes. We condu